December 12, 2025 a 07:43 am
KLAC: Fundamental Ratio Analysis - KLA Corporation
KLA Corporation operates in the technology sector, providing essential tools and solutions for the semiconductor industry. The stock symbol is KLAC, and the company exhibits a solid business structure with notable financial metrics. This analysis covers key aspects of KLA's fundamental performance and market position.
Fundamental Rating
KLA Corporation has a fundamental rating of B+, reflecting a strong financial position with some areas for improvement. Below are the specific scores for its financial performance metrics.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
Analysis of KLA Corporation's financials over time reveals stability in its performance metrics.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-12-11 | 3 | 4 | 5 | 5 | 1 | 2 | 1 |
| Historical Avg. | 3 | 4 | 5 | 5 | 1 | 2 | 1 |
Analyst Price Targets
The stock is seen as a positive investment opportunity by analysts, with various price targets indicating upward potential.
| High | Low | Median | Consensus |
|---|---|---|---|
| 1400 | 1214 | 1280 | 1294.86 |
Analyst Sentiment
Analysts have a generally positive sentiment towards KLA Corporation, predominantly issuing buy recommendations.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 23 | |
| Hold | 18 | |
| Sell | 2 | |
| Strong Sell | 0 |
Conclusion
KLA Corporation's stock analysis reveals it as a robust prospect in the semiconductor sector resting on a solid business foundation. With a strong ROE and ROA, the company exhibits a capability for consistent returns. While debt management remains an area for enhancement, analyst sentiment and price target analysis suggest potential upside. Investors should weigh the opportunities against market volatility and sector-specific risks.